Maze Therapeutics Inc (MAZE)

Stock-Based Compensation

$26.23M

TTM · Period ending: · USD

MAZE logo

MAZE Stock-Based Compensation

Latest reported$26.23M
MAZE TTM Stock-Based Comp ($9.12M → $26.23M)
High-resolution chart · PNG

MAZE stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Maze Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
26,233,000
20,283,000
16,400,000
13,178,000
11,657,000
10,562,000
9,646,000
9,352,000
9,122,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.